Search

everythinglearnresearchcommunity

for

Search:↓

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Age is more important than BMI for IVF success in women with infertility and PCOS.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Long-term use of minoxidil may cause hair follicles to transform into noticeable terminal hairs, leading to trichostasis spinulosa.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Treatment improved some symptoms but not all.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Female pattern alopecia causes hair thinning due to shrinking hair follicles.

Women with excessive body hair often have higher male hormones and related health issues.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Fetal wound healing changes with development, affecting inflammation and collagen, which may influence scarring.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

miR-21 helps improve ovarian function recovery in treated mice.

The technique successfully reconstructed a functional neo-vagina with 100% survival and patency, but lacked mucus secretion.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Finasteride causes lasting fertility decrease in rats.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.